🔎 Trials Near Me

Beranda › Infeksi Saluran Pernapasan › Texas

Uji klinis Infeksi Saluran Pernapasan di Texas

5 studi untuk Infeksi Saluran Pernapasan mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Amarillo
  • Research Site, Dallas
  • Research Site, El Paso
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Cedar Health Research, Dallas
  • Cedar Health Research, Euless
  • DM Clinical Research-Cyfair, Houston
  • dan 1 lainnya
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Zenos Clinical Research, Dallas
  • Southwest Family Medicine Associates, Dallas
  • Southwest Mind and Body Care, Dallas
  • dan 9 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Zenos Clinical Research, Dallas
  • Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
  • Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
  • dan 8 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474

An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.

  • The University of Texas Health Science Center at Houston, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT06070688

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.